Wells Fargo’s Celyad Oncology SA American Depositary Shares CYAD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-570
| Closed | -$546 | – | 7776 |
|
|
2023
Q1 | $546 | Hold |
570
| – | – | ﹤0.01% | 6534 |
|
|
2022
Q4 | $281 | Sell |
570
-12,300
| -96% | -$12.5K | ﹤0.01% | 6528 |
|
|
2022
Q3 | $18K | Sell |
12,870
-1,000
| -7% | -$1.84K | ﹤0.01% | 5470 |
|
|
2022
Q2 | $24K | Sell |
13,870
-3,750
| -21% | -$7.5K | ﹤0.01% | 5369 |
|
|
2022
Q1 | $42K | Sell |
17,620
-1,015
| -5% | -$3.1K | ﹤0.01% | 5741 |
|
|
2021
Q4 | $69K | Buy |
18,635
+10,850
| +139% | +$45.6K | ﹤0.01% | 5819 |
|
|
2021
Q3 | $32K | Buy |
7,785
+1,445
| +23% | +$6.32K | ﹤0.01% | 5799 |
|
|
2021
Q2 | $34K | Hold |
6,340
| – | – | ﹤0.01% | 5715 |
|
|
2021
Q1 | $45K | Sell |
6,340
-1,943
| -23% | -$15.3K | ﹤0.01% | 5862 |
|
|
2020
Q4 | $65K | Sell |
8,283
-1,704
| -17% | -$14.6K | ﹤0.01% | 5511 |
|
|
2020
Q3 | $99K | Buy |
9,987
+4,047
| +68% | +$40.8K | ﹤0.01% | 5271 |
|
|
2020
Q2 | $63K | Sell |
5,940
-1,000
| -14% | -$9.76K | ﹤0.01% | 5419 |
|
|
2020
Q1 | $52K | Sell |
6,940
-14,561
| -68% | -$138K | ﹤0.01% | 5324 |
|
|
2019
Q4 | $224K | Buy |
21,501
+12,913
| +150% | +$130K | ﹤0.01% | 4881 |
|
|
2019
Q3 | $87K | Buy |
8,588
+810
| +10% | +$10K | ﹤0.01% | 5383 |
|
|
2019
Q2 | $89K | Buy |
7,778
+164
| +2% | +$3.13K | ﹤0.01% | 5353 |
|
|
2019
Q1 | $155K | Buy |
7,614
+1,390
| +22% | +$29.7K | ﹤0.01% | 4944 |
|
|
2018
Q4 | $113K | Buy |
6,224
+179
| +3% | +$4.32K | ﹤0.01% | 5223 |
|
|
2018
Q3 | $160K | Buy |
6,045
+5,545
| +1,109% | +$162K | ﹤0.01% | 5130 |
|
|
2018
Q2 | $15K | Buy |
+500
| New | +$15.4K | ﹤0.01% | 5883 |
|
Other funds holding CYAD
Wells Fargo's CYAD Position: Q2 2023 in Review
Wells Fargo sold out of Celyad Oncology SA American Depositary Shares (CYAD) in Q2 2023, closing a stake of 570 shares — an estimated $546 sold.
Wells Fargo first reported a position in CYAD in Q2 2018 and held it in 20 quarters. The position peaked at $224K in Q4 2019. 2 funds tracked by Wall St. Rank hold CYAD as of Q2 2023.
- Wells Fargo reported no remaining Celyad Oncology SA American Depositary Shares position as of Q2 2023 after selling out during the quarter.
- Wells Fargo sold 570 Celyad Oncology SA American Depositary Shares shares in Q2 2023, an estimated $546.
- Wells Fargo first reported a position in Celyad Oncology SA American Depositary Shares in Q2 2018 and held it in 20 quarters.
- Wells Fargo's Celyad Oncology SA American Depositary Shares position peaked at $224K in Q4 2019.
- 2 funds tracked by Wall St. Rank held Celyad Oncology SA American Depositary Shares as of Q2 2023.
Based on Wells Fargo's 13F filing for Q2 2023, filed 15 Aug 2023.